Dual scaffold delivery of miR-210 mimic and miR-16 inhibitor enhances angiogenesis and osteogenesis to accelerate bone healing
Acta Biomaterialia · 2023
DOI: 10.1016/j.actbio.2023.09.049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2023. Verfasst von Irene Mencía Castaño und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Engineering Research Group, Department of Anatomy, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephens Green, Dublin 2, Ireland. Hauptthemen laut MEDLINE: Osteogenesis, MicroRNAs. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Advanced Materials and Bioengineering Research, Health Research Board.
Abstract (Originalsprache)
Angiogenesis is critical for successful bone repair, and interestingly, miR-210 and miR-16 possess counter-active targets involved in both angiogenesis and osteogenesis: miR-210 acts as an activator by silencing EFNA3 & AcvR1b, while miR-16 inhibits both pathways by silencing VEGF & Smad5. It was thus hypothesized that dual delivery of both a miR-210 mimic and a miR-16 inhibitor from a collagen-nanohydroxyapatite scaffold system may hold significant potential for bone repair. Therefore, this systems potential to rapidly accelerate bone repair by directing enhanced angiogenic-osteogenic coupling in host cells in a rat calvarial defect model at a very early 4 week timepoint was assessed. In vitro, the treatment significantly enhanced angiogenic-osteogenic coupling of human mesenchymal stem cells, with enhanced calcium deposition after just 10 days in 2D and 14 days on scaffolds. In vivo, these dual-miRNA loaded scaffolds showed more than double bone volume and vessel recruitment increased 2.3 fold over the miRNA-free scaffolds. Overall, this study demonstrates the successful development of a dual-miRNA mimic/inhibitor scaffold for enhanced in vivo bone repair for the first time, and the possibility of extending this 'off-the-shelf' platform system to applications beyond bone offers immense potential to impact a myriad of other tissue engineering areas. STATEMENT OF SIGNIFICANCE: miRNAs have potential as a new class of bone healing therapeutics as they can enhance the regenerative capacity of bone-forming cells. However, angiogenic-osteogenic coupling is critical for successful bone repair. Therefore, this study harnesses the delivery of miR-210, known to be an activator of both angiogenesis and osteogenesis, and miR-16 inhibitor, as miR-16 is known to inhibit both pathways, from a collagen-nanohydroxyapatite scaffold system to rapidly enhance osteogenesis in vitro and bone repair in vivo in a rat calvarial defect model. Overall, it describes the successful development of the first dual-miRNA mimic/inhibitor scaffold for enhanced in vivo bone repair. This 'off-the-shelf' platform system offers immense potential to extend beyond bone applications and impact a myriad of other tissue engineering areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tissue Engineering Research Group, Department of Anatomy, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephens Green, Dublin 2, Ireland.
- Tissue Engineering Research Group, Department of Anatomy, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephens Green, Dublin 2, Ireland; School of Pharmacy, RCSI, Dublin, Ireland.
- Department of Physiology and Medical Physics, Centre for the Study of Neurological Disorders, Microsurgical Research and Training Facility, RCSI, Dublin 2, Ireland.
- Cellular and Molecular Imaging Core, RCSI, Dublin 2, Ireland.
- Tissue Engineering Research Group, Department of Anatomy, Royal College of Surgeons in Ireland (RCSI), 123 St. Stephens Green, Dublin 2, Ireland; Trinity Centre for Biomedical Engineering, Trinity College Dublin (TCD),…
Förderung
- European Regional Development Fund
- Advanced Materials and Bioengineering Research
- Health Research Board
- European Research Council
- Science Foundation Ireland
Zitieren
APA
Castaño, I. M., Raftery, R. M., Chen, G., Cavanagh, B., Quinn, B., Duffy, G. P., Curtin, C. M., & O'Brien, F. J. (2023). Dual scaffold delivery of miR-210 mimic and miR-16 inhibitor enhances angiogenesis and osteogenesis to accelerate bone healing. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2023.09.049
Vancouver
Castaño IM, Raftery RM, Chen G, Cavanagh B, Quinn B, Duffy GP, et al. Dual scaffold delivery of miR-210 mimic and miR-16 inhibitor enhances angiogenesis and osteogenesis to accelerate bone healing. Acta Biomaterialia. 2023. doi:10.1016/j.actbio.2023.09.049
BibTeX
@article{Castao2023,
author = {Castaño, Irene Mencía and Raftery, Rosanne M and Chen, Gang and Cavanagh, Brenton and Quinn, Brian and Duffy, Garry P and Curtin, Caroline M and O'Brien, Fergal J},
title = {Dual scaffold delivery of miR-210 mimic and miR-16 inhibitor enhances angiogenesis and osteogenesis to accelerate bone healing},
journal = {Acta Biomaterialia},
year = {2023},
doi = {10.1016/j.actbio.2023.09.049}
}
EUVIMED